Literature DB >> 22948385

Motivation for change and barriers to treatment among young cannabis users.

S Fernández-Artamendi1, J R Fernández-Hermida, G García-Fernández, R Secades-Villa, O García-Rodríguez.   

Abstract

BACKGROUND/AIMS: Despite cannabis use among adolescents has shown to be related to psychosocial and mental health problems, the demand from adolescents for professional help is very low, and determinants of motivation for change among nonclinical populations remain unknown. The purpose of this study was to assess motivation for change among young cannabis users and to identify determinants of intention to change and self-change, as well as perceived barriers to seeking professional help.
METHODS: 261 cannabis users aged 16-21 participated in a computerized survey in Spain.
RESULTS: Data from this cross-sectional study indicated that few users intend to stop taking the drug. Determining factors of intention to change were the following: having more drug-related problems, paranoid symptomatology and greater concern about the consequences of use. Self-change was facilitated by lower use of cannabis, and could be hindered by tobacco smoking and cannabis dependence. Lack of awareness of the problems and the desire to solve one's problems alone constitute the main barriers to seeking professional help.
CONCLUSIONS: Adolescent cannabis users show low motivation for change though experiencing more problems associated with its use emerges as a determinant of increased motivation. Several barriers impede this motivation from turning into treatment demand.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22948385     DOI: 10.1159/000339582

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  8 in total

1.  BSAFER: A Web-based intervention for drug use and intimate partner violence demonstrates feasibility and acceptability among women in the emergency department.

Authors:  Esther K Choo; Caron Zlotnick; David R Strong; Daniel D Squires; Chantal Tapé; Michael J Mello
Journal:  Subst Abus       Date:  2015-12-29       Impact factor: 3.716

2.  Comparing Cannabis Use Disorder in the General Population with Cannabis Treatment Seekers Using Multi-Source National Datasets: Who Receives Treatment?

Authors:  Deirdre Mongan; Anne Marie Carew; Derek O'Neill; Seán R Millar; Suzi Lyons; Brian Galvin; Bobby P Smyth
Journal:  Eur Addict Res       Date:  2021-10-13       Impact factor: 3.015

3.  Characterizing symptoms of cannabis use disorder in a sample of college students.

Authors:  Alexa J Pellegrino; Kerry D Duck; Dylan P J Kriescher; Mackenzie E Shrake; Michael M Phillips; Trent L Lalonde; Kristina T Phillips
Journal:  J Drug Issues       Date:  2020-07-04

4.  mHealth App for Cannabis Users: Satisfaction and Perceived Usefulness.

Authors:  Grégoire Monney; Louise Penzenstadler; Olivia Dupraz; Jean-François Etter; Yasser Khazaal
Journal:  Front Psychiatry       Date:  2015-08-27       Impact factor: 4.157

5.  Why treatment is not an option: Treatment naïve individuals, suffering from alcohol use disorders' narratives about alcohol use and treatment seeking.

Authors:  Kristine Tarp; Sengül Sari; Anette Sogaard Nielsen
Journal:  Nordisk Alkohol Nark       Date:  2022-04-21

6.  The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study.

Authors:  Michael A P Bloomfield; Celia J A Morgan; Shitij Kapur; H Valerie Curran; Oliver D Howes
Journal:  Psychopharmacology (Berl)       Date:  2014-04-03       Impact factor: 4.530

7.  Can reduce--the effects of chat-counseling and web-based self-help, web-based self-help alone and a waiting list control program on cannabis use in problematic cannabis users: a randomized controlled trial.

Authors:  Michael P Schaub; Severin Haug; Andreas Wenger; Oliver Berg; Robin Sullivan; Thilo Beck; Lars Stark
Journal:  BMC Psychiatry       Date:  2013-11-14       Impact factor: 3.630

8.  The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial.

Authors:  Manuel Amann; Severin Haug; Andreas Wenger; Christian Baumgartner; David D Ebert; Thomas Berger; Lars Stark; Marc Walter; Michael P Schaub
Journal:  JMIR Res Protoc       Date:  2018-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.